“…The overall procedural safety was comparable to earlier generations of the device, with potentially lower occurrence of phrenic nerve injury [ 31 ]. In a prospective study comparing the 2nd (LB2) and 3rd generation (LB3) LBA systems, Heeger et al [ 32 ] demonstrated significant reductions in total procedure time (LB2: 91 (IQR: 86, 105) min vs. LB3: (77 (IQR: 68, 87) min; p < 0.001) and laser ablation time (LB2: 1920 (IQR: 1765, 2193) s vs. LB3: 1077 (896, 1165) s; p < 0.000001) without difference in occurrence of major adverse events (LB2: 1/15 (6.7%) vs. LB3: 1/15 (6.7%); p = 0.999). Further, while pulmonary vein diameter, shape, and branching can adversely affect AF-free survival with CB PVI ablation [ 33 , 34 ], PV anatomy does not seem to hold similar negative impact on clinical outcomes for LBA, particularly as the introduction of LB2 system, because of the compliant, adjustable sized balloon design which confirms readily to most PV anatomy [ 35 ].…”